Results

Total Results: 1,531 records

Showing results for "drugs".

161. New AHRQ Toolkit Helps Clinical Teams Implement Decolonization To Prevent Infections | Agency for Healthcare Research and Quality
     ce.effectivehealthcare.ahrq.gov/news/newsletters/e-newsletter/807.html
     April 01, 2022 - References for 14 high-priority DDIs identified external factors beyond the drugs themselves that could

162. dfdfl;kdf (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/data/SyH-DR-Removal-of-Synthetic-Drug-ID-January2024.pdf
     January 01, 2024 - dfdfl;kdf AHRQ Publication No. 24-0031-3-EF January 2024 Synthetic Healthcare Data for Research (SyH-DR) Known Data Issue: Removal of Synthetic Drug ID If you downloaded the SyH-DR data files before January 2024, you will see a variable called Synthetic Drug ID (SYNTHETIC_DRUG_ID), which does not contain any va…

163. Preparing for Ambulatory Computerized Prescriber Order Entry by Evaluating Preimplementation Medication Errors (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol2/Devine.pdf
     July 01, 2003 - The background tables included those that linked drugs to dosage forms and doses, provided directions … Further, the background tables that linked drugs to dosage forms and doses were too restrictive. … The programmer also unlinked drugs from dosage forms and doses, allowing the research associates to

164. Pediatric Patient Safety Consortium (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA202-Materials_XIII.pdf
     January 01, 2014 - For drugs and biologicals only: In order for an application for a code for a drug/biological can be … drugs and not biologics, the applicant must submit 3 months of marketing experience following the … This question must be answered for all items, except drugs/biologicals. … Note: FDA approval for drugs accepted up to 90 days after the application deadline. … Note: Marketing data requirements waived for drugs only.

165. Pediatric Patient Safety Consortium (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA204-Materials_XIII.pdf
     August 25, 2014 - For drugs and biologicals only: In order for an application for a code for a drug/biological can be … drugs and not biologics, the applicant must submit 3 months of marketing experience following the … This question must be answered for all items, except drugs/biologicals. … Note: FDA approval for drugs accepted up to 90 days after the application deadline. … Note: Marketing data requirements waived for drugs only.

166. Pediatric Patient Safety Consortium (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA205-Materials_XIII.pdf
     August 13, 2014 - For drugs and biologicals only: In order for an application for a code for a drug/biological can be … drugs and not biologics, the applicant must submit 3 months of marketing experience following the … This question must be answered for all items, except drugs/biologicals. … Note: FDA approval for drugs accepted up to 90 days after the application deadline. … Note: Marketing data requirements waived for drugs only.

167. Adverse Drug Events Occurring in U.S. Hospitals | Agency for Healthcare Research and Quality
     ce.effectivehealthcare.ahrq.gov/data/infographics/adverse-drug-events.html
     August 01, 2018 - Skip to main content An official website of the Department of Health and Human Services Careers Contact Us Español FAQs Search all AHRQ sites Search small Search Menu …

168. Final Progress Report: Prescription Opioid Use Trajectories and Risk Factors Associated with Opioid-Related Hospitalizations in Older Adults (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/2024-02/wei-report.pdf
     January 01, 2024 - duplications, 39.1% vs 15.5%; chronic opioid use, 22.4% vs 9.0%; and concurrent use of opioids and CNS-active drugs … opioid use (≥90 days) 22.4 9.0 2.8 (2.1, 3.8) 2.7 (2.0, 3.7) Concurrent use of opioids and other CNS drugs … ¥CNS drugs included antipsychotics, benzodiazepine, non-benzodiazepine or hypnotics, tricyclic antidepressants … The receipt of duplicated opioids, chronic opioid use, or concurrent use of opioids with other CNS drugs

169. The Impact of Personal Digital Assistant Devices on Medication Safety in Primary Care (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol3/Galt.pdf
     January 01, 2005 - and applications selected for this study were the Sony Clie’ PEG-SJ30™ (Sony Corporation), and Lexi-Drugs … Employing information technology (IT) strategies and systems to prescribe drugs holds substantial additional

170. Adverse Drug Events (ADE) | Agency for Healthcare Research and Quality
     ce.effectivehealthcare.ahrq.gov/topics/adverse-drug-events-ade.html
     Skip to main content An official website of the Department of Health and Human Services Careers Contact Us Español FAQs Search all AHRQ sites Search small Search Menu …

171. Standardizing Medication Error Event Reporting in the U.S. Department of Defense (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol4/Nosek.pdf
     March 01, 2004 - another study found that nearly 10 percent of all hospital admissions are related to problematic use of pharmaceuticals … top 10 drug products included in both the DoD and national datasets are considered “high-risk/alert” drugs … Additionally, 9 of the 10 leading “harm” drugs in the DoD data and 8 of the 10 leading “harm” drugs … in the national data are considered “high-risk/alert” drugs (Table 3).

172. Translating Patient Safety Research into Clinical Practice (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol2/Magid.pdf
     January 01, 2004 - decision support system that was added to an existing computerized order entry system for prescribing drugs … Protocols for high-risk drugs: reducing adverse drug events related to anticoagulants.

173. State Variation in Opioid Prescription Fills After Childbirth Among Women Ages 18-44 With Commercial Insurance (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/data/SyH-DR-stat-brief-2-postpartum-opioid-rx.pdf
     March 01, 2024 - Opioids excluded from our analysis include respiratory agents, antitussives, and drugs commonly used

174. PowerPoint Presentation
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/teamstepps/longtermcare/module5/ts2-0ltc_module5_slides_sitmon.pptx
     February 03, 2006 - ‹#› Situation Monitoring I’M SAFE Checklist I = Illness M = Medication S = Stress A = Alcohol and Drugs

175. The Effective Health Care Program | Agency for Healthcare Research and Quality
     ce.effectivehealthcare.ahrq.gov/cpi/about/otherwebsites/effectivehealthcare.ahrq.gov/index.html
     March 01, 2024 - The Centers for Education & Research Therapeutics (CERTs) conduct research and education about drugs

176. Well-Child Visits on the Rise, But Disturbing Gaps Remain for Underserved Populations | Agency for Healthcare Research and Quality
     ce.effectivehealthcare.ahrq.gov/news/newsletters/e-newsletter/828.html
     August 01, 2022 - Skip to main content An official website of the Department of Health and Human Services Careers Contact Us Español FAQs Search all AHRQ sites Search small Search Menu …

177. Tool: SSA (doc file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/mvp/modules/technical/sat-sbt-litreview.docx
     January 01, 2017 - medical patients requiring mechanical ventilation who were receiving continuous infusion of sedative drugs … An evidence-based strategy for administering these drugs can lead to improvements in short- and long-term … on 128 adult patients who were receiving mechanical ventilation and continuous infusions of sedative drugs … An evidence-based strategy for administering these drugs can lead to improvements in short-and long-term

178. National Healthcare Safety Network (NHSN) Laboratory-Identified Event (LabID Event): Surveillance for C. difficile Infection (CDI) and Drug-Resistant Organisms (MDROs) | Agency for Healthcare Research and Quality
     ce.effectivehealthcare.ahrq.gov/nursing-home/resources/nhsn-lab-id-event.html
     April 01, 2022 - Skip to main content An official website of the Department of Health and Human Services Careers Contact Us Español FAQs Search all AHRQ sites Search small Search Menu …

179. CHIPRA 212 Appendix 1 (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-212-appendix-1.pdf
     January 24, 2024 - CHIPRA 212 Appendix 1 Inhaled Corticosteroid for Children with Persistent Asthma Prescribed at Time of Discharge from the Emergency Department APPENDIX 1 - ASTHMA DRUG AND DEVICE Asthma Drug and Device NDC Code Brand Name Generic Product Name Route Category Drug ID Device FDA -Age (Years) Chamber Cha…

180. Infographic - More Opioid-Related Emergency Visits, No Change in Illicit Drug Use Treatment (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/data/infographics/emergency-visits-opioids.pdf
     September 27, 2021 - Infographic - More Opioid-Related Emergency Visits, No Change in Illicit Drug Use Treatment This Is a Sample Two Line Infographic Arial BK - 24 PT Source: The source should be in 8.5/10 point Arial. The source should be in 8.5/10 point Arial. The source should be in 8.5/10 point Arial. The source should be in 8.5/1…